Safety and Early Hints of Benefit Seen in Phase 1b Trial of PF-04447943
News
Sickle cell disease (SCD) patients were safely treated with a phosphodiesterase 9A (PDE9) inhibitor therapy called PF-04447943 with no serious side effects reported and possible evidence of fewer vaso-occlusion ... Read more